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Abstract: Exposure to environmental pollutants, including dioxin-like polychlorinated biphenyls
(PCBs), play an important role in vascular inflammation and cardiometabolic diseases (CMDs) by
inducing oxidative stress. Earlier, we demonstrated that oxidative stress-mediated lipid peroxidation derived 4-hydroxy-2-nonenal (4HNE) contributes to CMDs by decreasing the angiogenesis of
coronary endothelial cells (CECs). By detoxifying 4HNE, aldehyde dehydrogenase 2 (ALDH2), a mitochondrial enzyme, enhances CEC angiogenesis. Therefore, we hypothesize that ALDH2 activation
attenuates a PCB 126-mediated 4HNE-induced decrease in CEC angiogenesis. To test our hypothesis,
we treated cultured mouse CECs with 4.4 µM PCB 126 and performed spheroid and aortic ring
sprouting assays, the ALDH2 activity assay, and Western blotting for the 4HNE adduct levels and
real-time qPCR to determine the expression levels of Cyp1b1 and oxidative stress-related genes. PCB
126 increased the gene expression and 4HNE adduct levels, whereas it decreased the ALDH2 activity
and angiogenesis significantly in MCECs. However, pretreatment with 2.5 µM disulfiram (DSF), an
ALDH2 inhibitor, or 10 µM Alda 1, an ALDH2 activator, before the PCB 126 challenge exacerbated
and rescued the PCB 126-mediated decrease in coronary angiogenesis by modulating the 4HNE
adduct levels respectively. Finally, we conclude that ALDH2 can be a therapeutic target to alleviate
environmental pollutant-induced CMDs.
Keywords: angiogenesis; 3, 30 , 4, 40 , 5-pentachlorobiphenyl (PCB 126); environmental pollutants;
coronary endothelial cells; aldehyde dehydrogenase 2; 4-hydroxy-2-nonenal
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1. Introduction
Angiogenesis is the sprouting of new blood vessels from preexisting vessels. It is one of
the most important physiological properties of endothelial cells (ECs) of the vascular tissue.
Angiogenesis is essential in both physiological and pathological conditions, including
embryonic development, organ perfusion, wound healing, tissue regeneration, and tumor
growth [1]. Coronary angiogenesis is critical to maintain proper cardiac perfusion for
regulating cardiac function, metabolism, and tissue regeneration. Decreased coronary
angiogenesis leads to cardiometabolic diseases (CMDs), including cardiomyopathy, heart
failure with preserved ejection fraction (HFpEF), and myocardial ischemia–reperfusion
injury (IRI) [2]. The regulation of angiogenesis depends on a dynamic balance between
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proangiogenic and antiangiogenic processes [1]. Dysregulation of the balance between
proangiogenic and antiangiogenic factors leads to either excess or insufficient angiogenesis.
Environmental pollutants play an important role in several pathological conditions,
including cardiovascular diseases, pulmonary diseases, renal disease, and cancer. For
instance, a study on 22 people with type 2 diabetes showed that exposure to fine airborne
particulate matter (PM2.5 ) caused immediate endothelial dysfunction that was characterized by a reduced flow-mediated dilatation and small-artery elasticity index [3]. In addition
to airborne pollutants, persistent organic pollutants, especially halogenated pollutants,
have been implicated in cardiovascular risks. Dioxins and dioxin-like chemicals are a
group of structurally related persistent organic pollutants that are largely generated by
humans through industrial processes, including incineration, the production of herbicides
and pesticides, and the use of fertilizers. Dioxins are highly toxic and have been found to
work through a common mechanism of action that is mediated through activation of the
Aryl hydrocarbon receptor (AhR). One class of dioxin-like pollutants, known as dioxin-like
polychlorinated biphenyls (PCBs), including PCB 126, PCB 77, and PCB 169, have been
manufactured as mixtures and utilized in a variety of commercial products, including
additives to sealants and paints and in oils used in industrial processes for their insulation
and fire-retardant properties. Dioxin-like polychlorinated biphenyl (PCB) 126 is one of
the potent dioxin-like PCBs and a well-known environmental pollutant that is implicated
in causing severe toxicity due to its bioaccumulation [4]. PCBs were eventually banned
in the United States in the late 1970s and then worldwide in 2001 after the Stockholm
Convention. Prior to this ban, multiple occupational and accidental exposures occurred,
but now, the primary source of exposure to PCBs is through contaminated food, including
high-fat foods such as meat, fish, and dairy products. Since PCBs are now ubiquitous
contaminants in the global food chain, even humans in the general population have a
body burden of PCBs and other dioxin-like pollutants. A cross-sectional analysis of 1844
men in their 50s and free of cardiovascular disease showed that dietary exposure to PCBs
was associated with a higher prevalence of coronary calcium levels and intense subclinical coronary atherosclerosis [5]. Another population-based prospective investigation of
the vasculature in Uppsala seniors (PIVUS) with 1016 participants showed an increase
in atherosclerotic plaque formation in the carotid artery, along with an elevation of the
serum PCBs levels independent of the cardiovascular risk factors, including lipids [6].
A separate population-based study examining the PIVUS cohort demonstrated that the
prevalence of left ventricular hypertrophy is positively correlated with the serum levels
of PCBs, including PCB 118, 126, 169, and 156 [7]. Another prospective population-based
study that recruited 32,952 women and 36,546 men free from cancer, cardiovascular disease,
and diabetes at the baseline showed that dietary exposure to PCBs was associated with an
increased risk of HF in both women and men [8]. Several preclinical studies determined the
role of PCBs in different pathophysiological conditions. For instance, an in vivo study on
rodents showed increased body weights, impaired insulin sensitivity; reduced adipose tissue deposition; and elevated serum triglycerides, cholesterol, and insulin levels, along with
increased free radical generation and altered protein levels related to oxidative stress in the
islets of Langerhans upon PCB 126 exposure [9]. Another study by the same research group
showed that the intranasal administration of PCB 126 exerts an innate immune deficiency
that was characterized by the impairment of adhesion receptors on blood leukocytes and
reduced blood neutrophil locomotion and G protein-coupled receptor (GPCR)-mediated
activation of an oxidative burst in rats [10]. The administration of PCB 126 in mice through
oral gavage increased the plasma levels of the inflammatory markers of the peripheral
vasculature, including ICAM-1, plasminogen activator inhibitor-1, and proatherogenic
trimethylamine-N-oxide [11]. Another in vitro study showed that a treatment with 0.03 nM
PCB 126 significantly increased the expression of vascular inflammatory mediators, including interleukin (IL)-6, C-reactive protein (CRP), intercellular adhesion molecule-1 (ICAM-1),
vascular cell adhesion molecule-1 (VCAM-1), and IL-1α/β, in the cultured human umbilical vein endothelial cell (HUVEC) lines [12]. Low-density lipoprotein receptor knockout
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mice showed increased levels of plasma proinflammatory cytokines, increased circulating
biomarkers of CVD, altered platelet and red blood cell counts, an increased accumulation
of hepatic fatty acids, and accelerated atherosclerotic lesion formation in the aortic root
after 10 weeks of PCB 126 exposure [13]. In addition to proinflammatory, hypertrophic,
and pro-atherosclerotic effects, PCBs have antiangiogenic effects as well. For instance, PCB
treatment in HUVECs significantly decreased angiogenesis compared with the controls, as
evident from an in vitro tube formation assay on Matrigel, as well as an aortic ring assay
using mouse aorta [14].
Previously, we demonstrated that PCB 126 has a role in endothelial cell dysfunction,
oxidative stress, and accelerated atherosclerosis [13], but its impacts on coronary angiogenesis have not been studied yet. In our cell culture studies using mouse coronary endothelial
cells (MCECs), we demonstrated that a direct exogenous treatment of 4-hydroxy-2-nonenal
(4HNE), a secondary metabolite of oxidative stress that is generated upon lipid peroxidation, reduces angiogenesis [1]. This antiangiogenic effect of 4HNE was aggravated by
inhibiting aldehyde dehydrogenase 2 (ALDH2), a mitochondrial enzyme that metabolizes
4HNE, by pharmacologically inhibiting ALDH2 activity with disulfiram (DSF) [1]. In
animal studies, we also found reduced coronary angiogenesis in mice with low intrinsic ALDH2 activity due to diabetic stress or a single-point mutation (E487K) in ALDH2,
termed ALDH2*2 [15]. When we subjected the ALDH2*2 mutant diabetic mouse hearts to
ischemia–reperfusion injury (IRI), we found the augmented apoptosis of CD31+ coronary
endothelial cells, along with increased 4HNE adduct formation, compared to wild-type
diabetic mouse hearts that underwent similar IRI [15].
Roughly ~30% of East Asians, i.e., ~400 million people, carry the ALDH2*2 mutation, leading to an increased incidence of cardiovascular diseases, including myocardial
infarction, coronary spasm, diabetic cardiac complications, and heart failure [16]. Several East Asian countries have high environmental pollution, and the people in those
countries experience PCB-induced health hazards. A recent study from China reported
that ALDH2*2 mutant patients with metabolic disorders such as diabetes mellitus have
a higher incidence of HF with preserved ejection fraction (HFpEF), a disease originating
from coronary endothelial dysfunction [17].
Thus, understanding the mechanism of PCB 126-induced coronary endothelial cell
damage can be beneficial in preventing several critical CMDs, including HFpEF. In this
study, we specifically plan to determine if PCB 126-induced coronary endothelial cell damage is mediated via 4HNE and if modulating ALDH2 activity plays a role in this process.
2. Materials and Methods
2.1. Experimental Animal
Aortas from six-month-old C57BL/6 mice were used for this study. Mice were bred and
maintained in the animal care facility at Henry Ford Health System. Mice were humanely
euthanized, and aortas were isolated for the aortic ring assay. The animal protocols were
approved by the Wayne State University Institutional Animal Care and Use Committee,
which conforms to NIH standards.
2.2. Cell Culture
The mouse coronary EC (MCEC) line was obtained from Cedarlane (#CLU510) and
grown as we already described [1]. We used MCECs after the fourth passage, and they were
grown in new DMEM supplemented with 0.2% FBS (low serum) and 1% P/S. After 24 h of
low-serum treatment, the cells were used to perform the spheroid assay and subjected to
the treatment protocols, as described below.
2.3. Treatment Protocols
Protocol 1: We treated MCECs with 4.4 µM of PCB 126 (AccuStandard Inc., New
Haven, CT, USA) or the vehicle (dimethyl sulfoxide (DMSO) (#sc 358801)) for 24–72 h,
followed by the extraction of mRNA and the protein to perform real-time polymerase
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Protocol 2: We treated MCECs with the vehicle (DMSO) or disulfiram (DSF) (#sc205654A) (2.5 μM), an ALDH2 inhibitor, or Alda 1 (#A5823, Acme Bioscience) (10 µ M), an
ALDH2 activator, for 2 h before challenging with PCB 126 (4.4 µ M) for 24 h. Finally, we
extracted mRNA and proteins for real-time PCR (RT-qPCR) or Western blot analysis (Figure 1B).
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2.4. Spheroid Assay
For making spheroids (~400 cells/spheroid), we diluted them in 4 mL of DMEM
supplemented with 10% FBS, 1% P/S, and 20% Methocel (#M7027-250G, SIGMA). To form
spheroids, we incubated the plate upside-down in a humidified incubator set at 37 ◦ C with
a continuous supply of 5% CO2 for 24 h. We then transferred the spheroid suspension in a
15-mL conical tube and centrifuged it at 200× g for 5 min. We aspirated the supernatant
and added 2 mL ice-cold Methocel containing 20% FBS. Separately we prepared a 4 mL
collagen stock solution by adding 1 mg/mL collagen (#32160405, MilliPORE SIGMA) in
ice-cold DMEM supplemented with 10% FBS, 1% P/S, and 30 ng/mL VEGF (#493-MV,
R&D Systems). We mixed ice-cold Methocel containing the spheroids with collagen stock
solution and subsequently pipetted 250 µL of collagen stock containing the spheroids in
each well of a 24-well cell culture plate. We incubated the plates containing the spheroids
in a humidified incubator at 37 ◦ C with a continuous supply of 5% CO2 for 1 h to solidify
the collagen bed due to polymerization. We added 250 µL of DMEM supplemented with
10% FBS, 1% P/S, and 30 ng/mL VEGF in each well of the 24-well plate containing the
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collagen bed with spheroids embedded in it and subsequently incubated in a humidified
incubator at 37 ◦ C with a continuous supply of 5% CO2 for 1 h. Then, we treated the
spheroids according to the protocol mentioned in Figure 1C. We captured images of sprout
growth from the spheroids embedded in the collagen matrix using a 10× phase–contrast
microscope. To determine the angiogenesis, we counted the number of nodes in sprouted
spheroids under a high-power field (HPF) using ImageJ software.
2.5. Aortic Ring Assay
We performed the aortic ring assay as described previously [18]. Briefly, we isolated
the aorta and washed with sterilized PBS to remove the residual blood. We immediately
transferred the cleaned aorta to a 100-mm plate containing fresh Opti-MEM (#51985-034,
ThermoFisher Scientific). Using a sharp and sterile scalpel, we dissected the aorta into
small ring-like fragments with an approximate length of 1 mm. From a single aorta, we
made 28–34 aortic rings. Using a sterile sharp-tipped tweezer, we transferred the aortic
rings to a new 60-mm/6-well plate containing DMEM supplemented with 0.2% FBS and
1% P/S. We pipetted 200 µL of the collagen stock into each well of a 24-well plate and
subsequently planted three aortic rings in each well on the top of the collagen bed using a
sharp-tipped sterile tweezer. We planted the aortic rings on the collagen bed so that the
luminal axis was perpendicular to the bottom of the well. Then, we incubated the plate in a
humidified incubator set at 37 ◦ C with a continuous supply of 5% CO2 for 1 h to solidify
the collagen bed due to polymerization. We added 100 µL of collagen stock to each well
on top of the aortic rings to embed them into the collagen bed. Then, we treated the aortic
rings according to the protocol we discussed elsewhere in the manuscript (Figure 1C). We
captured images of sprout growth from the aortic rings embedded in the collagen matrix
using a 10× phase–contrast microscope. We measured the relative sprouting area (%) from
each aortic ring under HPF to determine the angiogenesis using ImageJ software.
2.6. Real-Time qPCR
The total RNAs from MCECs purified by Trizol reagent (Invitrogen) were reversetranscribed to cDNA for quantifying with an Applied Biosystems QuantStudio 6 Flex
RT-qPCR System using SYBR Green (Applied Biosystems). Samples were analyzed as
duplicates, and the expression levels were calculated using the ∆∆Ct method. The PCR
primers are described in Table 1. The housekeeping gene, Beta-actin (Actb), is listed at the
bottom of the table. The PCB 126 treatment did not significantly impact the Actb expression.
Table 1. List of primers used for qPCR.
Gene

Forward

Reverse

NQO1

GGCATCCAGTCCTCCATCAA

GTTAGTCCCTCGGCCATTGTT

CAT

CAGAGAGCGGATTCCTGAGAGA

CTTTGCCTTGGAGTATGTGGTGAT

GSTM1

ATACTGGGATACTGGAACGTCC

AGTCAGGGTTGTAACAGAGCAT

GSR

TCGGAATTCATGCACGATCA

GGCTCACATAGGCATCCCTTT

TXNRD1

GGCCAAAATCGGTGAACACATGGAAG

CGCCAGCAACACTGTGTTAAATTCGCCC

GSTA1

AAGCCCGTGCTTCACTACTTC

GGGCACTTGGTCAAACATCAAA

GPX2

GTGGCGTCACTCTGAGGAACA

CAGTTCTCCTGATGTCCGAACTG

CYP1B1

AATGAGGAGTTCGGGCGCACA

GGCGTGTGGAATGGTGACAGG

ACTB

GCCACTGTCGAGTCGCGT

GATACCTCTCTTGCTCTGGGC
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2.7. ALDH2 Activity Assay
The ALDH2 activity was measured according to the protocol described elsewhere [18].
Briefly, MCECs were grown on 100-mm plates and treated according to the protocol in
Figure 1B, and cellular protein was extracted, and 100 µg of total cellular protein from each
sample was used for this assay. Freshly made 50 mM sodium pyrophosphate (#221368500G, SIGMA) solution as a buffer, 2.5 mM NAD+ (#N3014-5G, SIGMA) solution as a
cofactor, and 10 mM acetaldehyde (#402788-100ML, SIGMA) as a substrate were used.
The enzymatic activity of ALDH2 from cell lysate was determined spectrophotometrically
using the reductive reaction of NAD+ to NADH at a λ340-nm wavelength at 37 ◦ C.
2.8. Western Immunoblotting
4HNE protein adducts and ALDH2 protein levels were evaluated using the WB assay,
as we described earlier [18]. In brief, after treatment, the cellular protein was extracted
from cultured MCECs using a tissue protein extraction reagent (ThermoFisher Scientific)
containing protease/phosphatase inhibitors. Specific protein bands were separated using
SDS-PAGE, and the proteins were then transferred to nitrocellulose membranes. The membranes were blocked using 5% bovine serum albumin (BSA) and subsequently incubated
with 4HNE mouse mAb (#ABN249, Millipore Sigma) and GAPDH (G-9) Mouse mAb
(#sc-365062) primary antibodies at a concentration of 1:1000 overnight in a cold refrigerator
(4 ◦ C). Depending on the sources of the primary antibodies, the membrane-bound antibodies were incubated with anti-rabbit/anti-mouse horseradish peroxidase (HRP)-coupled
secondary antibodies (1:2000) for 1 h at room temperature. Immunolabeling was detected
using ECL detection reagents (ThermoFisher Scientific) according to the manufacturer’s
protocols. The images of the protein bands were taken with a FluorChem E imaging system.
The intensity of the scanned WB images was analyzed with ImageJ software (NIH). The
GAPDH protein was used as a loading control to normalize the proteins of interest.
2.9. Statistical Analysis
We compiled the experimental data and calculated the means and standard error of the
means (SEM) using Excel spreadsheets. To determine the statistical significance between
two groups, we performed the Student’s t-test, and for multiple groups, we employed
one-way/two-way ANOVA, followed by Tukey’s post hoc test analysis, using GraphPad
Prism 9.2.0.332 (GraphPad Software). We considered the level of significance at <0.05.
3. Results
3.1. PCB 126 Activates the Aryl Hydrocarbon Receptor and Increases Oxidative Stress in Cultured
Mouse Coronary Endothelial Cells
It is well-established that exposure to dioxin-like pollutants such as PCB 126 elicits a
xenobiotic detoxifying response through the activation of the AhR [19,20]. To examine if
the AhR targets were inducible in MCECs, we exposed the cells to 4.4 µM PCB 126 for 24
to 72 h. The PCB 126 treatment increased the expression of the AhR target gene Cyp1b1 at
24 h (p = 0.086; Figure 2). A well-established mechanism of dioxin-like pollutant toxicity is
an increase in oxidative stress. To examine this in the MCECs, we examined the mRNA
expression of the genes known to be oxidative stress-sensitive. Here, we measured the
representative antioxidant genes regulated by oxidative stress-sensitive NFE2-like BZIP
Transcription Factor 2 (NFE2L2 or NRF2) [21] after vehicle or 4.4 uM PCB 126 treatment for
24 h. The expression of Nqo1 (p = 0.0002), Cat (p = 0.0022), Gsr (p = 0.0009), Gsta1 (p = 0.0064),
and Txnrd1 (p = 0.0031) were significantly increased due to PCB 126 treatment (Figure 2),
and Gpx2 and Gstm1 showed no significant changes (data not provided).
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Figure 2. mRNA expression of Cyp1b1, Nqo1, Cat, Gsr, Gsta1, and Txnrd1 in PCB 126-treated MCECs.
mRNA2.expression
of AhR of
transcriptional
Cyp1b1,
the expression
of oxidative
stressFigure
mRNA expression
Cyp1b1, Nqo1,target
Cat, Gsr,
Gsta1,and
and Txnrd1
in PCB 126-treated
MCECs.
mRNA
expression
of AhR transcriptional
target Cyp1b1,
and the
expression
oxidative
stress-sensensitive
genes regulated
by the NRF2 pathway,
including
Nqo1,
Cat, Gsr,ofTxnrd1,
and
Gsta1, is
sitive
genes
the NRF2
including
Nqo1,
Cat,orGsr,
Gsta1, isSample
measmeasured
inregulated
MCECs 24by
h after
beingpathway,
treated with
the vehicle
(Red)
4.4 Txnrd1,
µm PCBand
126 (Black).
ured
after being
the**vehicle
or p4.4
m PCB
126 (Black).
Sample
size: in
n =MCECs
6. Data 24
arehshown
as thetreated
mean ±with
SEM.
p ≤ 0.01(Red)
and ***
≤ µ0.001;
otherwise,
the p-values
size: n = 6. Data are shown as the mean ± SEM. ** p ≤ 0.01 and *** p ≤ 0.001; otherwise, the p-values
are shown above the bar.
are shown above the bar.

To examine if the observed PCB 126-induced oxidative stress was resolved over time,
To examine
if the
observed
PCB
126-induced
oxidative
stress was
resolvedOur
overresults
time,
we next
completed
a time
course
to include
48 and
72-h exposure
durations.
we
next
completed
a time
course
to that
include
48 andstress-sensitive
72-h exposure genes
durations.
results
were
consistent
with
previous
data
oxidative
wereOur
induced
in
were
consistent
with
previous
data
that
oxidative
stress-sensitive
genes
were
induced
in
the PCB-treated group (Figure 3). The expression of Nqo1 showed a significant increase by
the
group
3). The
expression
showed
significant
PCBPCB-treated
126 treatment
at all(Figure
three time
points:
24 h, 48of
h, Nqo1
and 72
h, withaan
observedincrease
2.2-fold
by
PCB
126
treatment
at
all
three
time
points:
24
h,
48
h,
and
72
h,
with
an observed
2.2(p = 0.0489), 2.5-fold (p = 0.0026), and 1.5-fold (p = 0.0351) increase compared
with their
fold
(p
=
0.0489),
2.5-fold
(p
=
0.0026),
and
1.5-fold
(p
=
0.0351)
increase
compared
with
vehicle counterparts, respectively (Figure 3A). Significant differences in the expression of
their
vehicle
counterparts,
respectively
3A). Significant
the
exprescatalase
(Figure
3B) were observed
24 h (Figure
after treatment
(1.2-fold,differences
p = 0.0228),in
but
there
was
sion
of catalasedifference
(Figure 3B)
were observed
24 or
h after
(1.2-fold,
= 0.0228),
but
no significant
between
the vehicle
PCB treatment
126 at 48 and
72 h. pThe
expression
there
no significant
difference between
the
or126
PCB
126 at 48atand
h. The
of Gsrwas
(Figure
3D) was significantly
increased
byvehicle
the PCB
treatment
24 h72
(1.3-fold,
expression
Gsr
3D) pwas
significantly
by the PCB
126 treatment
at 24
p = 0.0112) of
and
48(Figure
h (1.3-fold,
= 0.0240)
but not increased
at 72 h. Similarly,
the expression
of Txnrd1
h(Figure
(1.3-fold,
p
=
0.0112)
and
48
h
(1.3-fold,
p
=
0.0240)
but
not
at
72
h.
Similarly,
the
expres3E) was significantly increased at 24 h (1.3-fold, p = 0.0096) and 48 h (1.3-fold,
sion
of Txnrd1
(Figure
3E) wasoccurred
significantly
at 24 h (1.3-fold,
p =(Figure
0.0096)3F)
andwas
48
p = 0.0271),
but
a resolution
by 72increased
h. The expression
of Gsta1
hsignificantly
(1.3-fold, p increased
= 0.0271), due
but atoresolution
occurred
by(2.6-fold,
72 h. Thep expression
of Gsta1
(Figure
PCB 126 only
at 24 h
= 0.0058). The
expression
of
3F)
was
significantly
increased
duetrend
to PCB
126 but
onlydid
at not
24 hreach
(2.6-fold,
p = 0.0058).
The
Gpx2
(Figure
3G) showed
a similar
to Gsr
significance
at any
of exthe
pression
ofpoints.
Gpx2 (Figure
3G)
showed
similar
trend to except
Gsr butfor
didGsr
notand
reach
significance
three time
Overall,
most
of theagenes
examined,
Gpx2,
showed a
downward
activation
time.most
For example,
the expression
Gsta1for
(Figure
3F)
at
any of thetrend
threeoftime
points.over
Overall,
of the genes
examined, of
except
Gsr and
in PCBshowed
126-treated
cells at 72
h was
decreased
compared
at expression
24 h (0.3-fold,
Gpx2,
a downward
trend
of significantly
activation over
time. For
example,tothe
of
p = 0.0367).
Gsta1
(Figure 3F) in PCB 126-treated cells at 72 h was significantly decreased compared to
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3.3. PCB 126 Increases the 4HNE Protein Adduct Levels, Whereas the Pharmacological
Activation of ALDH2 Rescues the PCB-Mediated Effects in Cultured Mouse Coronary
Endothelial Cells
The 4.4 µ M PCB 126 treatment in MCECs significantly increased the 4HNE protein
adduct levels compared with the control (p = 0.01) (Figure 5). However, a 10 µ M Alda 1
pretreatment for 2 h, followed by the treatment with PCB 126 for 24 h, rescued the PCB
126-mediated decrease in the 4HNE protein adduct levels (p = 0.006 vs. PCB 126) (Figure
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3.3. PCB 126 Increases the 4HNE Protein Adduct Levels, Whereas the Pharmacological Activation
of ALDH2 Rescues the PCB-Mediated Effects in Cultured Mouse Coronary Endothelial Cells
The 4.4 µM PCB 126 treatment in MCECs significantly increased the 4HNE protein
of 16
adduct levels compared with the control (p = 0.01) (Figure 5). However, a 10 µM10Alda
1 pretreatment for 2 h, followed by the treatment with PCB 126 for 24 h, rescued the PCB
126-mediated decrease in the 4HNE protein adduct levels (p = 0.006 vs. PCB 126) (Figure 5).
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10 µM Alda 1 pretreatment for 2 h, followed by the treatment with PCB 126 for 72 h, rescued
the PCB 126-mediated decrease in the sprout counts (p = 0.003 vs. PCB 126) (Figure 7B–D).
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The aortic ring assay data showed that 4.4 µ M PCB 126-treated aortic rings significantly decreased the sprouting area compared with the vehicle (p = 0.002) (Figure 7A,B,D).
A 10 µ M Alda 1 pretreatment for 2 h, followed by the treatment with PCB 126 for 72 h,
rescued the PCB 126-mediated decrease in the sprout counts (p = 0.003 vs. PCB 126) (Figure
7B–D).
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4. Discussion
This study suggests that PCB 126 increases AhR activation upregulation, as well as
the expression of oxidative stress-sensitive genes and decreases angiogenesis in cultured
MCECs by decreasing the activity of ALDH2 while increasing the 4HNE adduct levels.
Some of these PCB 126-mediated effects were exacerbated by ALDH2 inhibition using
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4. Discussion
This study suggests that PCB 126 increases AhR activation upregulation, as well as
the expression of oxidative stress-sensitive genes and decreases angiogenesis in cultured
MCECs by decreasing the activity of ALDH2 while increasing the 4HNE adduct levels.
Some of these PCB 126-mediated effects were exacerbated by ALDH2 inhibition using DSF,
whereas these effects were rescued by ALDH2 activation with Alda-1.
Dioxins and dioxin-like chemicals are a group of structurally related chemicals with
long half-lives that are largely generated by humans through industrial processes, including
incineration, the production of herbicides and pesticides, and the use of fertilizers [22].
Dioxins are highly toxic and have been found to work through a common mechanism of
action that is mediated through the activation of AhR [23]. Similar to dioxins, man-made
dioxin-like PCBs, such as PCB 126, have been manufactured and utilized as additives to
sealants and paints and in oils used in industrial processes [24,25]. In this study, when we
treated MCECs with PCB-126, there was a near-significant increase in the transcription of
the Cyp1b1 genes. Therefore, we can speculate on the activation of AhR and subsequent
upregulation of Cyp1b1 and other AhR target genes in MCECs.
These dioxin-like PCBs have a coplanar structure, leading to similar chemical characteristics, modes of action, and toxicities such as dioxins [26]. PCBs began to be mass
produced in the early 1930s and have been well-studied as one of the most toxic classes of
persistent organic pollutants of worldwide concern [24]. Due to their extreme chemical and
thermal stability, PCBs are highly resistant to degradation, leading to bioaccumulation in
the environment and in the fatty tissues of animals and humans [27]. As we mentioned
earlier, PCBs were eventually banned in the United States in the late 1970s and then worldwide in 2001 after the Stockholm Convention [24,28]. Since this ban, the primary source of
exposure to PCBs has been through contaminated food, including high-fat foods such as
meat, fish, and dairy products [29,30]. Since PCBs are now ubiquitous contaminants in the
global food chain, even humans in the general population have been exposed to PCBs [31].
Numerous epidemiological studies have found that exposure to PCBs is often associated
with adverse human health effects, including vascular diseases (US EPA). Hypertension
has been associated with increased serum levels of dioxin-like PCBs in highly exposed populations, especially in younger populations [32,33]. The data analysis from the NHANES
(1999–2002) revealed that dioxin-like PCBs were positively associated with hypertension
but only among men [34]. Dietary exposure to PCBs was also shown to be associated
with increased coronary calcium and more intense atherosclerosis in the general male
population [5]. Experimental evidence has further highlighted the relationship between
exposure to dioxin-like PCBs and the accelerated development of atherosclerosis [13]. In
2013, a cross-sectional study of an elderly Swedish population revealed that high serum
levels of PCBs were associated with dysfunction of the left ventricle, independent of other
heart failure risk factors [35]. Furthermore, a study examining Swedish population-based
prospective cohorts from 1997 to 2010 found that dietary PCB exposure was associated
with an increased risk of HF in both women and men [8]. Thus, PCBs are associated with
cardiovascular diseases. In our study, we tested whether PCB-126 can increase oxidative
stress in cultured MCECs and found it enhanced the activation of AhR and corresponding
antioxidant genes Nqo1, Cat, Gsr, Gpx2, Gsta1, and Txnrd1. For most of the markers of
oxidative stress, the expression remained significantly elevated compared to the control
even 72 h after exposure.
CMDs are one of the major leading causes of death worldwide. One of the contributing factors to CMDs is oxidative stress. Since the human heart is utilizing 15 to 20 times
more than its own weight of the daily amount of adenosine triphosphate (ATP) for it to
function [36], this puts the heart under huge oxidative stress. The lipid peroxidation of
poly-unsaturated fatty acids (PUFAs) such as arachidonic acids by ROS and superoxide
is a critical component of oxidative stress [37]. The most prominent products of lipid
peroxidation are 4HNE-like reactive carbonyls [37]. Due to the oxidation process, the
peroxyl radical addition and disintegration of cardiolipin on the mitochondrial lipid mem-
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brane generate considerable amounts of 4HNE [38]. 4HNE can form covalent adducts in
several cellular signaling cascades [39]. Specialized enzyme systems such as glutathione
S-transferases (GSTs), glutathione (GSH), aldose reductase (AR), and ALDH are involved
in the detoxification of 4HNE-like reactive carbonyls.
We and others have shown that ALDH2 is key in conferring a cardioprotective role
by detoxifying 4HNE and reducing 4HNE-mediated toxicity [16,17,37,40–43]. Diabetesinduced CEC dysfunction contributes to diabetic heart disease, another important type of
CMD [15,44]. We reported that a decrease in ALDH2 activity, either by genetic modification [15] or pharmacological inhibition [1], exhibited poor angiogenesis. We also found
that 4HNE is directly involved in this low ALDH2 activity-mediated decrease in coronary
angiogenesis [15,18]. In another study, we show that ALDH2 activation improves Ang
II-mediated defective CEC angiogenesis by decreasing 4HNE-mediated cytotoxicity [45].
Similarly, in the current study, we found that PCB-126 increased 4HNE and reduced ALDH2
activity, along with angiogenesis. We also found a pharmacological inhibition of ALDH2
with DSF-potentiated PCB-126-induced decreased coronary angiogenesis. However, the
activation of ALDH2 by Alda-1 increased the coronary angiogenesis.
Thus, in conclusion, we propose that ALDH2 can be an important target in reducing
PCBs such as pollutant-mediated cellular toxicity in endothelial cells. Future studies
utilizing human cardiac endothelial cells and well-established rodent models of heart
failure will help to establish a clearer directive relationship between dioxin-like pollutant
exposure and heart failure risk. Finally, we conclude that ALDH2 activation can be a
therapeutic strategy to improve coronary angiogenesis to ameliorate CMDs like HFpEF.
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